Welcome to your Investor Page
Explore our Investor Portal for the latest company updates, financial information, and resources for investors. Stay informed about our progress and find the information you need.
Login to The Investor PortalThe DNA Company Announces a New Era in Personalized Health Insights
Corona, CA – July 6, 2026 For the first time, DNA360™ provides advanced genetic insights to help individuals and practitioners understand biological factors underlying hormone metabolism, cellular signaling pathways, and physiological responses relevant to hormone replacement therapy (HRT) and peptide-based wellness protocols.
Read Full ArticleLatest News & Press Releases
Stay updated with the latest announcements, media coverage, and company milestones. Our growing recognition in the health and biotech sectors underscores our leadership in functional genomics.
Why Similar Patients Can Respond Differently and What Functional Genomics May Add to the Picture
A recent feature in TopDoctor Magazine explored how The DNA Company, based in Corona, California, built its DNA360™ report around exactly this idea.
Read More →The DNA Company Takes Functional Genomics Beyond DNA Reports
The DNA Company's functional-genomics work added a genetics layer to that preventive model. The two businesses merged in 2022, prompting The DNA Company's move to California. Wood became chief operating officer in January 2023, helped build out a mobile primary-care and virtual-clinic strategy, and is credited with leading the company to its first profitable year before becoming CEO in July 2023.
Read More →The DNA Company Wins 2025 BioTech Breakthrough Award
Recognized as “Functional Genomics Innovation of the Year” for pioneering AI-driven platforms that decode individual genetic expression, setting a new standard for personalized health and longevity solutions.
Read More →Tracy Wood in MSN: Top 20 Women Leading Biohacking & Longevity
Our CEO was recognized among the most influential female leaders revolutionizing precision wellness, biohacking, and genetic-guided longevity protocols worldwide.
Read More →Dr. Krista Kostroman in Daily Mail: Groundbreaking Genetic Discovery
Our Chief Science Officer reveals a novel genetic pathway linked to metabolic resilience. This discovery could transform nutritional genomics and preventive medicine.
Read More →How functional genomics and epigenetics drive "precision wellness.
In this interview with Scott Douglas Jacobsen, Varden explains how functional genomics and epigenetics drive "precision wellness." She outlines The DNA Company's DNA360 test, which maps pathways—not just risk markers—to guide diet, sleep, detoxification, hormone balance, and mental resilience.
Read More →Meet Our Team
Visionary leadership driving the future of functional genomics and precision health.
Tracy Wood is a serial entrepreneur, healthcare executive, and technology innovator whose career has been defined by building companies that challenge traditional models and improve people's lives. Over three decades, she has founded, scaled, and led multiple organizations across telecommunications, healthcare, telemedicine, functional medicine, and precision health.
Alison Henry manages the day-to-day operations at The DNA Company as Chief Operations Officer. Her focus on operational excellence ensures that the company runs smoothly and efficiently, delivering high-quality products and services to our clients.
Dr. Krista Kostroman is the Senior Vice President at The DNA Company, where she oversees all scientific research and product development. With a background in naturopathic medicine, Dr. Kostroman bridges the gap between traditional medicine and cutting-edge genomics, ensuring that our products are both scientifically robust and holistically beneficial.
The Minds Who Brought the Science to Life
Our co-founders launched our mission to revolutionize healthcare through personalized genomics, driven by a unique blend of expertise, vision, and passion for transforming how we approach health and wellness. Explore the stories of the visionary leaders who pioneered the future of personalized medicine and empowered individuals to take control of their health through their unique genetic blueprint.
Dr. Mansoor Mohammad
Bryce Wylde
